Modification To VF Gel Plus
System, Vocal Cord Medialization. 510(k) K080956, from Coapt Systems, Inc. (Palo Alto, CA). Product code MIX, class 2.
As of Nov 22, 2026, K080956 is an FDA 510(k) held by Coapt Systems, Inc., substantially equivalent on Apr 25, 2008 after 22 days, with no recalls tied to it in FDA's recall database.
- Review time: 22 days
- Recalls: 0
- Cited as a predicate by: 2 devices
The VF Gel is indicated for vocal fold medialization in the treatment of vocal fold insufficiency, where insufficiency may be improved by injection of a soft tissue bulking agent. VF Gel injection augments the size of the displaced or deformed vocal fold so that it may meet the opposing fold at the midline for improved glottal closure.
- VF Gel PlusK071663 · Coapt Systems, Inc. · Feb 15, 2008
- VF LiquigelK083783 · Coapt Systems, Inc. · Sep 11, 2009
- Vocalis GelK081815 · Cytophil, Inc. · Jan 5, 2009
- Silk Voice (SMI-04)K240919 · Sofregen Medical · May 3, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Apr 3, 2008
- Review panel
- Ear, Nose, Throat
- Regulation
- 21 CFR 874.3620
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files